Utilizing Phase-Appropriate CMC Strategies Throughout Clinical Development
Summary: A chemistry, manufacturing and controls (CMC) strategy can significantly impact the time and costs required to move a drug candidate through clinical development. In both the regulatory and manufacturing aspects of drug development, phase-appropriate strategies can help focus available resources to efficiently achieve goals and move to the next milestone. Learn how to accelerate and de-risk clinical-stage drug programs by understanding phase-appropriate strategies that can give your molecule the best chance for success!